SGD-1910 is an antibody-drug conjugate (ADC) linker that combines the potent DNA crosslinking agent pyrrolobenzodiazepine (PBD) with the cleavable linker MC-Val-Ala, facilitating targeted cancer therapy. Reagent grade, for research use only.
Usually ships within 24 hours.